Coagulation and anticoagulation in idiopathic pulmonary fibrosis

Crooks Michael G., Hart Simon P.

Source: Eur Respir Rev 2015; 24: 392-399
Journal Issue: September
Disease area: Interstitial lung diseases, Pulmonary vascular diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Crooks Michael G., Hart Simon P.. Coagulation and anticoagulation in idiopathic pulmonary fibrosis. Eur Respir Rev 2015; 24: 392-399

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary hypertension in idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis
Year: 2010

Pulmonary hypertension in patients with idiopathic pulmonary fibrosis
Source: Eur Respir Mon 2012; 57: 148-160
Year: 2012


Pulmonary hypertension in patients with idiopathic pulmonary fibrosis and combined pulmonary fibrosis and emphysema: hemodynamic severity
Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle
Year: 2018

Diagnosis of pulmonary arterial hypertension in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 335s
Year: 2005

Angiogenesis in idiopathic pulmonary fibrosis
Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis
Year: 2020


Angiogenesis and coagulation in the development of pulmonary hypertension in idiopathic interstitial pneumonias (IIP)
Source: Eur Respir J 2005; 26: Suppl. 49, 540s
Year: 2005

Exacerbation of idiopathic pulmonary fibrosis
Source: International Congress 2016 – Russia Session
Year: 2016

PP217 – Modeling idiopathic pulmonary fibrosis on a lung-on-chip
Source: ERS Lung Science Conference 2021
Year: 2021

Accelerated ageing in idiopathic pulmonary fibrosis and pulmonary hypertension
Source: International Congress 2018 – Accelerated ageing in lungs
Year: 2018


Pulmonary hypertension in idiopathic pulmonary fibrosis with mild-to-moderate restriction
Source: Eur Respir J 2015; 46: 1370-1377
Year: 2015



Pulmonary hypertension in idiopathic pulmonary fibrosis: Utility of HRCT
Source: International Congress 2014 – COPD and PAH related imaging
Year: 2014

Abnormal coagulation and fibrinolysis in relation to deterioration of pulmonary function in idiopathic interstitial pneumonia
Source: Annual Congress 2007 - Pathogenesis of idiopathic interstitial pneumonia including idiopathic pulmonary fibrosis
Year: 2007


Antifibrotic choice in idiopathic pulmonary fibrosis
Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF)
Year: 2018

Pirfenidone in idiopathic pulmonary fibrosis
Source: Eur Respir J 2010; 35: 821-829
Year: 2010



Pirfenidone in idiopathic pulmonary fibrosis
Source: Eur Respir J 2010; 36: 695-696
Year: 2010



Idiopathic pulmonary fibrosis
Source: Eur Respir Monogr 2015; 68: 50-63
Year: 2015


Idiopathic pulmonary fibrosis
Source: Eur Respir Monogr 2013; 62: 37-53
Year: 2013


Idiopathic pulmonary fibrosis
Source: International Congress 2018 – State of the art session: Interstitial lung diseases
Year: 2018